Research

Sarcomas and Histiocytosis

Search publications

Publications

  • Brandt A, Löhers K, Beier M, Leube B, de Torres C, Mora J, Arora P, Jat PS and Royer-Pokora B.

    Establishment of a Conditionally Immortalized Wilms Tumor Cell Line with a Homozygous WT1 Deletion within a Heterozygous 11p13 Deletion and UPD Limited to 11p15

    PLoS One . 11(5): . Number of citations: 6

    [doi:10.1371/journal.pone.0155561]

  • Mora J.

    Dinutuximab for the treatment of pediatric patients with high-risk neuroblastoma

    EXPERT REVIEW OF CLINICAL PHARMACOLOGY . 9(5): 647-653. Number of citations: 39

    [doi:10.1586/17512433.2016.1160775]

  • Millan NC, Poveda MJ, Cruz-Martínez O and Mora J.

    Safety of bevacizumab in patients younger than 4 years of age

    CLINICAL & TRANSLATIONAL ONCOLOGY . 18(5): 464-468. Number of citations: 11

    [doi:10.1007/s12094-015-1389-5]

  • Lasorsa VA, Formicola D, Pignataro P, Cimmino F, Calabrese FM, Mora J, Esposito MR, Pantile M, Zanon C, De Mariano M, Longo L, Hogarty MD, de Torres C, Tonini GP, Iolascon A and Capasso M.

    Exome and deep sequencing of clinically aggressive neuroblastoma reveal somatic mutations that affect key pathways involved in cancer progression

    Oncotarget . 7(16): 21840-21852. Number of citations: 64

    [doi:10.18632/oncotarget.8187]

  • Thompson EM, Hielscher T, Bouffet E, Remke M, Luu B, Gururangan S, McLendon RE, Bigner DD, Lipp ES, Perreault S, Cho YJ, Grant G, Kim SK, Lee JY, Rao AA, Giannini C, Li KK, Ng HK, Yao Y, Kumabe T, Tominaga T, Grajkowska WA, Perek-Polnik M, Low DC, Seow WT, Chang KT, Mora J, Pollack IF, Hamilton RL, Leary S, Moore AS, Ingram WJ, Hallahan AR, Jouvet A, Fèvre-Montange M, Vasiljevic A, Faure-Conter C, Shofuda T, Kagawa N, Hashimoto N, Jabado N, Weil AG, Gayden T, Wataya T, Shalaby T, Grotzer M, Zitterbart K, Sterba J, Kren L, Hortobágyi T, Klekner A, László B, Pócza T, Hauser P, Schüller U, Jung S, Jang WY, French PJ, Kros JM, van Veelen MC, Massimi L, Leonard JR, Rubin JB, Vibhakar R, Chambless LB, Cooper MK, Thompson RC, Faria CC, Carvalho A, Nunes S, Pimentel J, Fan X, Muraszko KM, López-Aguilar E, Lyden D, Garzia L, Shih DJ, Kijima N, Schneider C, Adamski J, Northcott PA, Kool M, Jones DT, Chan JA, Nikolic A, Garre ML, Van Meir EG, Osuka S, Olson JJ, Jahangiri A, Castro BA, Gupta N, Weiss WA, Moxon-Emre I, Mabbott DJ, Lassaletta A, Hawkins CE, Tabori U, Drake J, Kulkarni A, Dirks P, Rutka JT, Korshunov A, Pfister SM, Packer RJ, Ramaswamy V and Taylor MD.

    Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis

    LANCET ONCOLOGY . 17(4): 484-495. Number of citations: 241

    [doi:10.1016/S1470-2045(15)00581-1]

  • Krauel L, Fenollosa F, Riaza L, Pérez M, Tarrado X, Morales-La Madrid A, Gomà J and Mora J.

    Use of 3D Prototypes for Complex Surgical Oncologic Cases

    WORLD JOURNAL OF SURGERY . 40(4): 889-894. Number of citations: 40

    [doi:10.1007/s00268-015-3295-y]

  • Rodriguez-Hernandez CJ, Mateo-Lozano S, Garcia-López M, Casalà C, Briansó F, Castrejon N, Rodriguez E, Suñol M, Carcaboso AM, Lavarino C, Mora J and de Torres C.

    Cinacalcet inhibits neuroblastoma tumor growth and upregulates cancer-testis antigens

    Oncotarget . 7(13): 16112-16129. Number of citations: 17

    [doi:10.18632/oncotarget.7448]

  • Johann PD, Erkek S, Zapatka M, Kerl K, Buchhalter I, Hovestadt V, Jones DT, Sturm D, Hermann C, Segura Wang M, Korshunov A, Rhyzova M, Gröbner S, Brabetz S, Chavez L, Bens S, Gröschel S, Kratochwil F, Wittmann A, Sieber L, Geörg C, Wolf S, Beck K, Oyen F, Capper D, van Sluis P, Volckmann R, Koster J, Versteeg R, von Deimling A, Milde T, Witt O, Kulozik AE, Ebinger M, Shalaby T, Grotzer M, Sumerauer D, Zamecnik J, Mora J, Jabado N, Taylor MD, Huang A, Aronica E, Bertoni A, Radlwimmer B, Pietsch T, Schüller U, Schneppenheim R, Northcott PA, Korbel JO, Siebert R, Frühwald MC, Lichter P, Eils R, Gajjar A, Hasselblatt M, Pfister SM and Kool M.

    Atypical Teratoid/Rhabdoid Tumors Are Comprised of Three Epigenetic Subgroups with Distinct Enhancer Landscapes

    Cancer Cell . 29(3): 379-393. Number of citations: 401

    [doi:10.1016/j.ccell.2016.02.001]

  • Kovar H, Amatruda J, Brunet E, Burdach S, Cidre-Aranaz F, de Alava E, Dirksen U, van der Ent W, Grohar P, Grünewald TG, Helman L, Houghton P, Iljin K, Korsching E, Ladanyi M, Lawlor E, Lessnick S, Ludwig J, Meltzer P, Metzler M, Mora J, Moriggl R, Nakamura T, Papamarkou T, Radic Sarikas B, Rédini F, Richter GH, Rossig C, Schadler K, Schäfer BW, Scotlandi K, Sheffield NC, Shelat A, Snaar-Jagalska E, Sorensen P, Stegmaier K, Stewart E, Sweet-Cordero A, Szuhai K, Tirado OM, Tirode F, Toretsky J, Tsafou K, Üren A, Zinovyev A and Delattre O.

    The second European interdisciplinary Ewing sarcoma research summit - A joint effort to deconstructing the multiple layers of a complex disease

    Oncotarget . 7(8): 8613-8624. Number of citations: 33

    [doi:10.18632/oncotarget.6937]

  • Monterrubio C, Pascual-Pastó G, Cano F, Vilà-Ubach M, Manzanares-Quintela A, Schaiquevich P, Tornero JA, Sosnik A, Mora J and Carcaboso AM.

    SN-38-loaded nanofiber matrices for local control of pediatric solid tumors after subtotal resection surgery

    Biomaterials . 79: 69-78. Number of citations: 42

    [doi:10.1016/j.biomaterials.2015.11.055]